E-LIB Suche - Ergebnisse für: Kobayashi, Roger

1

26 Survival and Clinical Outcomes of XLA Patients 55 years ..:

Chin, Aaron ; Ochs, Hans ; Kobayashi, Roger...
Clinical Immunology. 262 (2024) - p. 109968 , 2024

2

Subcutaneous Immunoglobulin 16.5% (Cutaquig) is Safe and Ef..:

Gupta, Sudhir ; DeAngelo, James ; Melamed, Isaac...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB326 , 2023

Link: https://doi.org/10.1016/..

3

Subcutaneous Immunoglobulin 16.5% (Cutaquig) in Primary Imm..:

Gupta, Sudhir ; DeAngelo, James ; Melamed, Isaac...
Clinical Immunology. 250 (2023) - p. 109402 , 2023

Link: https://doi.org/10.1016/..

4

Long-Term Safety, Efficacy, and Tolerability of Subcutaneou..:

Gupta, Sudhir ; Kobayashi, Roger ; Melamed, Isaac...
Journal of Allergy and Clinical Immunology. 147 (2021) 2 - p. AB76 , 2021

Link: https://doi.org/10.1016/..

5

Evaluating Safety, Tolerability, and Efficacy of Subcutaneo..:

Melamed, Isaac ; Gupta, Sudhir ; Kobayashi, Roger...
Journal of Allergy and Clinical Immunology. 147 (2021) 2 - p. AB75 , 2021

Link: https://doi.org/10.1016/..

6

Benefits of IVIG in Pediatric Acute-Onset Neuropsychiatric ..:

Melamed, Isaac ; Kobayashi, Roger ; O'Connor, Maeve...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

7

A Simple Method of Blood Collection to Detect Mutational Ch..:

Nguyen, Anh V.T. ; Minh Huong, Le Thi ; Segundo, Gesmar...
Journal of Allergy and Clinical Immunology. 141 (2018) 2 - p. AB23 , 2018

Link: https://doi.org/10.1016/..

8

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid..:

Wasserman, Richard L. ; Lumry, William ; Harris III, James...
Journal of Clinical Immunology. 36 (2016) 6 - p. 590-599 , 2016

Link: https://doi.org/10.1007/..

9

Immunoglobulin G4–related sclerosing disease of the paranas..:

Lindau, Robert H. ; Su, Yungpo Bernard ; Kobayashi, Roger.
Head & Neck. 35 (2012) 10 - p. , 2012

Link: https://doi.org/10.1002/..

10

Parvovirus B19-Induced Anemia as the Presenting Manifestati..:

Seyama, Kuniaki ; Kobayashi, Roger ; Hasle, Henrik...
The Journal of Infectious Diseases. 178 (1998) 2 - p. 318-324 , 1998

Link: https://www.jstor.org/st..

11

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Im..:

Gupta, Sudhir ; DeAngelo, James ; Melamed, Isaac...
Journal of Clinical Immunology. 43 (2023) 6 - p. 1414-1425 , 2023

Link: https://doi.org/10.1007/..

12

Subcutaneous immunoglobulin 16.5% for the treatment of pedi..:

Gupta, Sudhir ; Kobayashi, Roger H. ; Litzman, Jiří...
Expert Review of Clinical Immunology. 19 (2022) 1 - p. 7-17 , 2022

Link: https://doi.org/10.1080/..

13

Immune globulin therapy and kidney disease: Overview and sc..:

Kobayashi, Roger H ; Rigas, Michael T
American Journal of Health-System Pharmacy. 79 (2022) 17 - p. 1415-1423 , 2022

Link: https://doi.org/10.1093/..

14

Corrigendum: Clinical efficacy, safety and tolerability of ..:

Kobayashi, Roger H. ; Gupta, Sudhir ; Melamed, Isaac...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

15

Overview of Subcutaneous Immunoglobulin 16.5% in Primary an..:

Kobayashi, Roger H ; Litzman, Jiří ; Rizvi, Syed...
Immunotherapy. 14 (2022) 4 - p. 259-270 , 2022

Link: https://doi.org/10.2217/..